Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM.DL)
CAPS Rating:
The Company is an innovation-driven biopharmaceutical company focuses on discovering, developing and commercializing medicines to change the lives of patients with cancer and inflammatory diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked MLNM.DL yet. Tell us why you think MLNM.DL will outperform or underperform the market.
RSS Headlines
Fool UK
